tirzepatide weight loss clinic in cleveland oh study reveals what happens when patients stop taking GLP-1 drugs Medical Weight Loss Houston |

Lilly launched the self-pay vial program in August 2024 specifically to capture cash-paying weight-loss patients without insurance support

Ideal candidates typically include: Patients facing high upfront surgery costs Individuals with high deductibles under their health insurance plan Self-pay patients without insurance coverage Patients pursuing bariatric procedures not fully covered by insurance Individuals seeking structured monthly payments instead of lump-sum payments Patients managing obesity-related conditions such as sleep apnea who require timely surgical intervention Financing can be particularly helpful for patients who meet BMI and eligibility criteria for procedures but need financial flexibility to move forward

At the 0.25 mg starting dose, a single vial contains 20 weeks of doses, but the reconstituted solution will degrade before you use it all

10.2337/db06-0006 91

Proc Natl Acad Sci U S A 113:78587863